. 2022 Jul 29;12:935310. doi: 10.3389/fonc.2022.935310
Copyright © 2022 Fuller, Crabtree, Kane, Medbery, Pfeffer, Gray, Peddada, Royce and Chen
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Figure 4.
Freedom from biochemical recurrence for subgroups of unfavorable intermediate-risk patients.